Articles Tagged With:
-
Healthcare Worker Attitudes and Perceptions About Respiratory Protection
In an unusual qualitative study, healthcare workers revealed a variety of attitudes about respiratory protection equipment, including motivations and suspicions that could improve or undermine compliance.
-
Surprised by Joy: A Framework for Finding Meaning in Work
There may seem to be a chasm between healthcare work and the commonly understood meaning of “joy,” but the Institute of Healthcare Improvement (IHI) is dedicated to bringing the ambitious goal of “joy in work” into reality. The IHI framework is designed to reduce staff burnout while improving patient care and overall organizational performance.
-
Work Culture: Breaking Down Silos, Ending the Silence
Experts say workplace culture change — a critical issue in an era of pervasive burnout — must include leadership, but it often begins at the grassroots level with some simple but aggravating problem.
-
Researchers Examine Use of Dichloroacetate in Endometriosis Treatment
The authors of a new scientific paper indicate that dichloroacetate, investigated as a potential cancer treatment, may be effective against endometriosis. Finding a new treatment option would augment current treatment strategies of hormone therapy and surgery, which involve significant side effects and recurrence after treatment.
-
Research Focuses on Medroxyprogesterone Acetate in Cervical Cancer Prevention
Preliminary research suggests that medroxyprogesterone acetate, the active ingredient in the contraceptive injection DMPA, may be effective in preventing cervical cancer.
-
Policy Update Advocates Teen Access to Emergency Contraception
To help prevent unplanned pregnancy among adolescents, the American Academy of Pediatrics has issued an updated policy statement on emergency contraception (EC) to educate providers on use of EC in adolescents, and advocate for expanded access for teens.
-
Investigational Contraceptive Patch Clears FDA Panel Vote
Twirla, an investigational combined hormonal contraceptive patch, is under review by the FDA. In an October 2019 meeting, the patch received a 14 to 1 vote from the FDA’s Bone, Reproductive, and Urologic Drugs Advisory Committee.
-
FDA Approves Liletta IUD for Six Years of Effective Use
The FDA has approved the Liletta levonorgestrel intrauterine device (IUD) for six years of effective use. The 52 mg device, similar in size to the Mirena IUD, was approved for the U.S. in February 2015.
-
The Time for Contraceptive Revolution Is Now
While the 20th century yielded new contraceptives in the form of pills, rings, patches, intrauterine devices, and implants, it is time for new exploration into further birth control options.
-
Envenomations
Envenomations can occur from a variety of species. They can cause symptoms that range from minor skin irritation to systemic signs and symptoms, organ failure, and even death. Knowing the signs and symptoms of envenomation are important for management and disposition.